Evidence map›Paper›PMID 31450746›Full record

ArticleToxins2019

Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver Disease.

Apurva Lad, Robin C Su, Joshua D Breidenbach, Paul M Stemmer, Nicholas J Carruthers, Nayeli K Sanchez, Fatimah K Khalaf, Shungang Zhang, Andrew L Kleinhenz, Prabhatchandra Dube and 12 more

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Toxins · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Microcystin-LR activates serine/threonine kinases and alters the phosphoproteome in human HepaRG cells.Toxicon : official journal of the International Society on Toxinology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Apurva LadDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Robin C SuDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Joshua D BreidenbachDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Paul M StemmerInstitute of Environmental Health Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Nicholas J CarruthersInstitute of Environmental Health Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USA.
Nayeli K SanchezDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Fatimah K KhalafDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Shungang ZhangDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Andrew L KleinhenzDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Prabhatchandra DubeDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Chrysan J MohammedDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Judy A WestrickDepartment of Chemistry, Wayne State University, Detroit, MI 48202, USA.
Erin L CrawfordDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Dilrukshika PalagamaDepartment of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA.
David Baliu-RodriguezDepartment of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA.
Dragan IsailovicDepartment of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA.
Bruce LevisonDepartment of Pediatrics, University of Toledo, Toledo, OH 43614, USA.
Nikolai ModyanovDepartment of Physiology and Pharmacology, University of Toledo, Toledo, OH 43614, USA.
Amira F GoharaDepartment of Pathology, University of Toledo, Toledo, OH 43614, USA.
Deepak MalhotraDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Steven T HallerDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA. Steven.Haller@UToledo.edu.ORCID 0000-0002-6919-6342
David J KennedyDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA. David.Kennedy@UToledo.edu.ORCID 0000-0001-5265-0142
University of Toledo · USEugene Applebaum College of Pharmacy and Health Sciences · USWayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
Pilot Project ProgramP30ES020957 · NIEHS · WAYNE STATE UNIVERSITY · PI RUDEN, DOUGLAS M · 2014 to 2021
$10.1M
Orbitrap Velos with ETD for Wayne State ProteomicsS10OD010700 · OD · WAYNE STATE UNIVERSITY · PI STEMMER, PAUL M · 2012 to 2012
$575k
NCI NIH HHS P30 CA022453NIEHS NIH HHS P30 ES020957NIH HHS S10 OD010700
6 · The paper itself

Abstract

Microcystins are potent hepatotoxins that have become a global health concern in recent years. Their actions in at-risk populations with pre-existing liver disease is unknown. We tested the hypothesis that the No Observed Adverse Effect Level (NOAEL) of Microcystin-LR (MC-LR) established in healthy mice would cause exacerbation of hepatic injury in a murine model (Lepr

Indexed as

AnimalsDisease Models, AnimalDisease ProgressionDose-Response Relationship, DrugLiverMaleMarine ToxinsMiceMice, Inbred StrainsMicrocystinsNon-alcoholic Fatty Liver DiseaseOrgan SizeOxidative StressProteomicsSurvival AnalysisWater Pollutants, Chemicalcyanoginosin LRMarine ToxinsMicrocystinsWater Pollutants, ChemicalhepatotoxicityLeprdb/J miceMicrocystin-LRNon-alcoholic Fatty Liver DiseaseNo Observed Adverse Effect Leveloxidative stressTiO2 enriched phosphopeptides

Identifiers

PMID31450746
PMCPMC6783870
OpenAlexW2970709249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.